Overall Rating
Stock is stuck in an uninspiring six-month trading range.
Stock's dividend yield is attractive.
This company has been paying dividends for 21 years.
Dividend payouts are consistent, but increases small.
Earnings estimates are basically unchanged.
Recent Headlines
- Can NutriSystem Stock Stop Losing Weight? (NTRI)
Tue, Jul 15, 2008 - Foreign Pharmaceutical Dividend Winners (AZN, GSK)
Sun, Jul 6, 2008
Profile & Recommendation
Company Profile
Glaxo-Smith Kline- (GSK)-engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical and consumer health-related products. The company's Consumer Healthcare segment offers over-the-counter medicines, oral care, and nutritional healthcare products. Its products comprise Lucozade energy and sports drinks; Aquafresh and Sensodyne toothpastes and mouthwashes; Aquafresh and Dr Best toothbrushes; Panadol, a paracetamol/acetaminophen analgesic; Horlicks, a milk-based malted food and chocolate drinks; and Ribena, a blackcurrant juice-based drink. GlaxoSmithKline operates in the United States, Europe, Japan, the Asia Pacific, the Middle East, Latin America, Africa, and Canada. It has agreements with Anacor Pharmaceuticals, Inc.; Oncomed Pharmaceuticals, Inc.; Santaris Pharma A/S; and Targacept, Inc. The company was founded in 1935 and is headquartered in Brentford, the United Kingdom.
Based on our rating criteria, this stock has achieved a "Recommended" rating. Stocks with this rating are considered generally good investments.
Stock Notes
This large cap stock does make an attractive dividend stock investment at this time.



Direct Competitors
RSS Feeds